Accuray, Inc. (ARAY)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.27+0.30%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ARAY
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 88 industry peers · Company calendar date is not available
ARAY — earnings in line
Dated 2026-08-19
Results of Operations and Financial Condition. On August 19, 2026, Accuray Incorporated (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2026. A copy of the Company’s press release dated August 19, 2026, titled “Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results” is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information (including the exhibit hereto) is being…
Why it matters: New partnerships can boost innovation and performance. This helps with long-term growth.
Supportive ifNews of new partnerships with big tech firms like Samsung or RaySearch.
Worry ifNo new partnerships announced by the end of Q1 2027.
Why it matters: The end of the agreement could hurt Accuray's finances and growth plans. Investors must watch how this affects future operations.
Worry ifAccuray may show a big drop in revenue or higher losses in the next earnings report.
Less concerning ifAccuray might keep making steady or better money even after the deal ends.
Why it matters: Paying back shows the company is stable and helps lower debt.
Supportive ifThe company confirms it has fully paid back the 3.75% Convertible Senior Notes.
Worry ifThe company says there are problems or delays in paying back the convertible senior notes.
Why it matters: Better gross margin shows better cost control and efficiency.
Supportive ifGross margin improves to above 25% in the next quarterly report.
Worry ifGross margin declines further below 24% in the next quarterly report.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$355 on $10,000 · ±3.5% | How much price usually moves either way. |
| Bad day | $922 loss on $10,000 · 9.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,784 loss on $10,000 · 87.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Bringing back guidance shows better clarity and trust in future results.
Supportive ifManagement gives clear financial plans for 2026 during the Q4 earnings call.
Worry ifManagement takes back guidance again or gives no guidance during the Q4 call.
Why it matters: The earnings report will show how Accuray is doing financially. It will also show how they handle recent problems.
Watch forAccuray might report more money made and better profit in the earnings release.
Also watch forAccuray might report less money made and bigger losses than expected.
Why it matters: Compliance is key for the company to maintain its listing and investor confidence.
Worry ifThe company says it is back in line with Nasdaq listing rules.
Less concerning ifThe company gets a notice that it may be removed from Nasdaq.
Why it matters: A falling backlog may show weak demand. This could hurt future revenue.
Worry ifOrder backlog decreases more than 10% by the end of Q1 2027.
Less concerning ifOrder backlog goes up or stays the same.
Why it matters: Progress in these partnerships can improve Accuray's technology. This may help future growth.
Supportive ifLook for news about finalized deals or product launches with Samsung or RaySearch.
Worry ifNo updates or delays in partnerships may mean problems ahead.
Why it matters: Paying back these notes is important for Accuray's finances and investor trust.
Supportive ifAccuray says it has paid back the Convertible Senior Notes completely. There were no issues.
Worry ifAccuray has problems or delays in paying back the Convertible Senior Notes.
Why it matters: The reverse stock split aims to improve financial flexibility. Its effect on share price will indicate market confidence.
Watch forShare price stays steady or goes up after the reverse stock split.
Also watch forShare price drops a lot after the split, showing negative market feelings.
Why it matters: The company stopped giving revenue guidance. An update will help investors see future results.
Watch forManagement gives a new revenue range for Q4. This shows recovery from geopolitical issues.
Also watch forNo update on guidance. There is still uncertainty about revenue from global issues.
Why it matters: Doing these agreements well is important. It helps improve cash flow and financial options.
Supportive ifFinishing the TCW financing agreements and doing the reverse stock split.
Worry ifHolds ups or problems with the TCW financing agreements.
Why it matters: Following Nasdaq rules is key for Accuray to stay listed and get investors.
Supportive ifAccuray says it has met all Nasdaq rules.
Worry ifAccuray fails to meet Nasdaq compliance and faces delisting.
Why it matters: More product orders show stronger demand and better sales.
Supportive ifGross product orders exceed $50 million in the upcoming quarter.
Worry ifGross product orders remain below $50 million in the upcoming quarter.
Why it matters: A big drop in product revenue shows demand problems. This can hurt future growth.
Worry ifQ1 product revenue down year over year worse than -30%.
Less concerning ifQ1 product revenue declines less than -30% or shows signs of stabilization.
Why it matters: Service revenue growth is key for stability and profit. Growth shows good strategy execution.
Supportive ifService revenue growth rate exceeds 5% year over year in upcoming quarters.
Worry ifIf service revenue growth is below 3% year over year, performance may be weak.
Why it matters: A larger net loss raises worries about financial health and how well the company runs.
Worry ifNet loss in Q1 exceeds $10 million.
Less concerning ifA net loss of less than $10 million in Q1 shows better financial performance.